Patents Represented by Attorney Stephen G. Ryan
-
Patent number: 6685811Abstract: The invention relates to a method and a system, suitable for automation, for the, preferably preparative, separation of amphoteric macromolecules, e.g. proteins or peptides, wherein said method comprises the steps of: (a) subjecting said mixture of macromolecules to isoelectric focusing in liquid media; (b) collecting samples from step (a), said samples containing macromolecules separated on basis of isoelectric point, and transferring each sample to a channel (13) accommodating medium for electrophoresis, said channel (13) being part of a composite body (14); (c) subjecting said samples, contained in the channels (13) in said composite body (14), to electrophoresis; and (d) allowing electrophoresis to proceed until macromolecules are eluted from said medium for electrophoresis, and collecting fractions of the samples containing macromolecules.Type: GrantFiled: May 16, 2001Date of Patent: February 3, 2004Assignee: Amersham Biosciences ABInventor: Ylva Laurin
-
Patent number: 6683302Abstract: The present invention relates to electrospray device and a method for heating a liquid in said electrospray device. The device comprising a liquid source (3), a mass analyser (5), and inlet plate (17) with an inlet orifice (19), liquid inlet means such as a capillary tube (9) having a spray tip (11) for emitting liquid from said liquid source (3) and it further comprises microwave energy emitting means (21) between said spray tip (11) and said mass analyser (5) for heating said liquid.Type: GrantFiled: August 28, 2002Date of Patent: January 27, 2004Assignee: Amersham Biosciences ABInventor: Johan Eriksson
-
Patent number: 6664058Abstract: The present invention describes novel compounds of the formula Wherein Q is H or a sugar or a sugar analogue or a nucleic acid backbone or backbone analogue, Y=O, S, NR10, where R10 is H, alkyl alkenyl, alkynyl, X is H, alkyl, alkenyl, alkynyl, aryl, heteroaryl or a combination thereof or, preferably, a reporter group. The novel compounds are suitable for incorporation in oligonucleotides and polynucleotides.Type: GrantFiled: July 3, 2001Date of Patent: December 16, 2003Assignees: Amersham Biosciences UK Limited, Medical Research Council Laboratories of Molecular BiologyInventors: Shiv Kumar, Satyam Nampalli, Constantin Neagu, Mark McDougall, David Loakes, Dan Brown
-
Patent number: 6656876Abstract: A storage stable composition comprising a carrier usable for the immobilization of compounds containing an amine group, for instance biomolecules and/or affinity ligands. The carrier has been activated to exhibit a squaric acid derivative linked to the carrier and is placed in contact with an aqueous medium. A kit comprising the storage stable composition is also disclosed.Type: GrantFiled: May 22, 2001Date of Patent: December 2, 2003Assignee: Amersham Biosciences ABInventor: Per-Mikael Åberg
-
Patent number: 6641735Abstract: A novel method for separating a target substance, for example, metal ion, drug or biological component is provided. According to the method, the surface of a packing undergoes a chemical or physical environmental change under a physical stimulus so that the interaction of a substance interacting with the target substance is reversibly changed in an aqueous solution, thus effecting separation.Type: GrantFiled: March 23, 2000Date of Patent: November 4, 2003Assignees: Japan Chemical Innovation Institute, The Agency of Industrial Science and Technology the Ministry of International Trade and IndustryInventors: Kimihiro Yoshizako, Yoshikatsu Akiyama, Katsuhiko Ueno, Teruo Okano
-
Patent number: 6635174Abstract: A matrix including: a) a polymeric base matrix including macropores (pore system 1) and b) an interior material, possibly porous (pore system 2), retained within the macropores. The matrix is characterized in that there is a continuous free volume between the interior material and the pore walls of the macropores. A method for manufacturing a matrix including a base matrix having macropores in which an interior material is located. The method is characterized in including the steps: (I) providing a base matrix having macropores; (ii) filling the macropores with a soluble form of the interior material; (iii) transforming the insoluble from to an insoluble form; (iv) shrinking the insoluble form; and (v) irreversibly stabilizing the material in its shrunken form. The matrix can be used in separation methods, cell culturing, solid phase synthesis of organic molecules, and in catalytic reactions (such as enzyme reactions) and other uses in which porous support matrices are used.Type: GrantFiled: February 12, 2002Date of Patent: October 21, 2003Assignee: Amersham Biosciences ABInventors: Hans Berg, Mats Carlsson
-
Patent number: 6613884Abstract: A method for removing a serum albumin from a mixture of other compounds by contacting said mixture with a ligand a) having affinity for and enabling selective binding of the serum albumin and b) being attached to a base matrix insoluble in the aqueous media used or being possible to attach to such a matrix after having become bound to the serum albumin, characterized in that said ligand is derived from an albumin binding bacterial cell surface receptor and that the ligand lacks the IgG-binding and/or &agr;2-macroglobulin-binding ability found in native forms of these type of bacterial receptors. An albumin-binding ligand derived from a cell surface bacterial receptor and attached covalently to a carrier matrix, characterized in that the ligand is monovalent with respect to ability to bind a serum albumin. A method for removal of serum albumin from a sample that is to be assayed for non-serum albumin components.Type: GrantFiled: February 15, 2001Date of Patent: September 2, 2003Assignee: Amersham Biosciences ABInventor: Hans Johansson
-
Patent number: 6610208Abstract: Spillage of liquid during switching of receptacles in a fraction collector is avoided by introducing a device in the flow path between an inlet tube and a dispensing means. The device includes an expandable chamber that accommodates liquid during the time interval for switching from one receptacle to the next receptacle.Type: GrantFiled: April 29, 2002Date of Patent: August 26, 2003Assignee: Amersham Biosciences ABInventor: Lars Andersson
-
Patent number: 6610200Abstract: This application discloses liquid chromatographic system including units selected from: a) a block (4) for distributing a liquid flow to a vessel (8), the characteristics being that there are through passing channels (7) comprising a narrow part (7a) and a widening part (7b), optionally with one check valve function per channel; b) a predistributor comprising a network of pipes starting at a pump (1), the characteristics being that the branches are narrowing down when going from the pump to the end pipes (3), and that each end pipes (3) have constriction means (19) providing for a significant pressure drop; c) a distributor with a distributor chamber (9) having an inlet pipe (11) equipped with sprinkler means (20); d) a tiltable chromatographic vessel (8) having a valve (15, 42) in its top and being possible to tilt 180° thereby facilitating emptying through the valve; the individual subunits and their use are also claimed.Type: GrantFiled: September 14, 2001Date of Patent: August 26, 2003Assignee: Amersham Biosciences ABInventors: Patrik Leijon, Anders Tärnström, Klaus Gebauer
-
Patent number: 6602990Abstract: A process for the production of a porous cross-linked polysaccharide gel and a gel obtainable by the following steps: a) preparing a solution or dispersion of the polysaccharide; b) adding a bifunctional cross-linking agent having one active site and one inactive site to the solution or dispersion from step a); c) reacting hydroxylgroups of the polysaccharide with the active site of the cross-linking agent; d) forming a polysaccharide gel; e) activating the inactive site of the cross-linking agent; f) reacting the activated site from step e) with hydroxylgroups of the polysaccharide gel, whereby cross-linking of the gel takes place. The cross-linked polysaccharide gel obtained can further be cross-linked by conventional methods, one or several times.Type: GrantFiled: May 11, 1999Date of Patent: August 5, 2003Assignee: Amersham Biosciences ABInventor: Hans Berg
-
Patent number: 6590096Abstract: The present invention relates to a method for producing porous polysaccharide beads, comprising: (a) mixing a water-based solution of a polysaccharide under stirring with an essentially water-immiscible first organic phase to form an emulsion which separates into two continuous phases; (b) adding a second organic phase comprising an emulsifier and an organic solvent to form a three-phase system; (c) allowing the three-phase system to emulsify; and (d) decreasing the temperature below the gelling point of the polysaccharide, thereby obtaining beads having two sets of pores, said method being characterised in that the emulsifier is a water-insoluble polymer capable of stabilizing said three-phase system.Type: GrantFiled: May 18, 2001Date of Patent: July 8, 2003Assignee: Amersham Biosciences ABInventors: Hans Berg, Mats Carlsson
-
Patent number: 6576124Abstract: The present invention relates to a chromatography column 1 in which the net 129 and/or bed support 131 is integrally joined to a net retaining means, preferably a sleeve 135 that protrudes through the column end plate 5, and/or to a net retaining circumferential ring. Different net retaining means are also presented.Type: GrantFiled: March 9, 2001Date of Patent: June 10, 2003Assignee: Amersham Biosciences ABInventors: Ulf Pichl, John Davis
-
Patent number: 6572766Abstract: A matrix is disclosed including a core showing a system of micropores and a surface in which the micropore system has openings. The characterizing feature is that the surface is coated with a polymer (I) having such a large molecular weight that it cannot penetrate into the micropores.Type: GrantFiled: January 24, 2000Date of Patent: June 3, 2003Assignee: Amersham Biosciences ABInventors: Jan Bergström, Rolf Berglund, Lennart Söderberg
-
Patent number: 6573053Abstract: A method of comparing genomic DNA from two individuals who share a phenotype, cutting the DNA into fragments long enough to contain on average one or several polymorphisms; combining the fragments under hybridisation conditions and recovering mismatch—free heterohybrids, wherein adapters resistant to nuclease digestion are ligated to the ends of the genomic fragments. A related method uses pooled genomic DNA from individuals with a common phenotype. Another related method uses restricted nucleic acid fragments likely to contain on average less than one natural polymorphism.Type: GrantFiled: September 24, 2001Date of Patent: June 3, 2003Assignee: Amersham Biosciences UK LimitedInventors: Greg Firth, Rajesh Muru Odedra
-
Patent number: 6569911Abstract: A method of manufacturing a support media from a cross-linked polymerisate based on vinyl compounds, and exhibiting residual vinyl groups. The characteristic feature of the method is that the polymerisate is subjected to a heating step that preferably is carried out under reduced access of oxygen. The use of the support media is also described.Type: GrantFiled: March 5, 2001Date of Patent: May 27, 2003Assignee: Amersham Biosciences ABInventors: Torunn Arntsen, Jan Roger Karlson, Geir Fonnum, Steinar Hagen
-
Patent number: 6569306Abstract: A cassette and electrophoretic gel assembly includes a non-conductive cassette, two solid buffer reservoirs, and an agarose gel. The assembly is disposable, and the sample wells on the gel are in standard microtiter plate format. The configuration is such that the gel is continuously in electrical contact with the electrodes in operation despite the production/migration of water and other exudates.Type: GrantFiled: April 10, 2000Date of Patent: May 27, 2003Assignee: Amersham Pharmacia Biotech, Inc.Inventors: Doug Read, Lori Hennessy, Mohammed Rezaul Islam
-
Patent number: 6562320Abstract: This invention relates to a freeze-dried vesicle containing ultrasound contrast agent containing a freeze-drying stabilizer and thermally stable at temperatures in excess of 20° C.Type: GrantFiled: June 26, 2000Date of Patent: May 13, 2003Assignee: Amersham Health ASInventors: Marit Swaerd-Nordmo, Per Helge Gulliksen, Jorunn Undheim Braenden, Anne Kjersti Fahlvik
-
Patent number: 6534488Abstract: The present invention relates to 32P or 33P-labelled bisphosphonates as radiotherapeutic radiopharmaceuticals. The 32P- or 33P-labelled bisphosphonates, which are chemically identical to the unlabelled agent, are expected to target the lesion site in an identical manner, but also deliver a significant radiocytotoxic effect to the surrounding cells. This should result, given the favorable energetics of the &bgr; particle emission from the 33P nuclide, in a loss of proliferative capacity of cells associated with the tumor lesion. The relative stability and in vivo localisation of bisphosphonates makes them good candidates as 32P/33P delivery vehicles.Type: GrantFiled: May 8, 2002Date of Patent: March 18, 2003Assignee: Amersham plcInventors: Alexander Mark Gibson, Marivi Mendizabal, Richard Pither, Shirley Elizabeth Pullan, Vaughan Griffiths, Philip Duncanson
-
Patent number: 6528319Abstract: A method for anchoring oligonucleotides containing multiple reaction sites to a substrate. The substrate can be glass, inorganic or organic polymer, and metal. The reactive group of the substrate can contain electophilic C═C double bonds for a nucleophilic addition, or disulfide for disulfide exchange. The multiple reactive groups contained on the oligonucleotide primer can be, for example, aminoalkyl, sulfhydryl, and thiophosphate groups. The oligonucleotide primer may take the configuration of a gairpin having a loop containing multiple reactive sites. In particular, a method for attaching an oligonucleotide primer to a glass substrate is disclosed that comprises preparing a bromoacetamide derivatized silane glass surface on a glass substrate, and reacting the bromoacetamide derivatized silane glass surface with an oligonucleotide primer containing multiple thiophosphate groups to bind the oligonucleotide primer to the glass substrate.Type: GrantFiled: September 2, 1999Date of Patent: March 4, 2003Assignee: Amersham Biosciences CorpInventor: Xiaodong Zhao
-
Patent number: 6524786Abstract: The invention concerns scintillation proximity assays performed in multiwell plates where a charge coupled device is used to image the wells. Conventional phosphors emit blue light (350-450 nm) which is absorbed by yellow or brown assay components. This problem is addressed by the use of phosphors that emit radiation of longer wavelength (480-900 nm).Type: GrantFiled: May 16, 2000Date of Patent: February 25, 2003Assignee: Amersham plcInventor: Robert A. Jessop